CiteAb announces Sino Biological as a ‘Protein supplier to watch in 2021’ and ‘Supplier succeeding in SARS-CoV-2 research
June 30th, 2021 – Bath, United Kingdom – CiteAb, the world’s premier life sciences data provider, recently announced Sino Biological, Inc. as the “Protein Supplier to Watch in 2021”. In addition, Sino Biological was given the designation “Supplier Succeeding in SARS-CoV-2 Research”. These awards are specifically established by CiteAb for the scientific research industry, and are awarded based upon the provision of superior product reference data. The “Protein Supplier to Watch in 2021” award is typically given to the bioreagent supplier yielding the largest percentage increase in protein reagent citations from the previous year. The “Supplier Succeeding in SARS-CoV-2 Research” award is a brand-new award recognizing a supplier that has reacted quickly to the events of 2020 and has achieved success with products related to COVID-19. It demonstrates an ability to be agile, and a contribution towards fighting the global pandemic that has kept most countries in a state of lockdown over the past year. This is the seventh consecutive year in which the CiteAb Awards have been announced, and in the past CiteAb has nominated top-tier bioreagent suppliers from around the world.
“Congratulations to Sino Biological for being named CiteAb Protein Supplier to Watch in 2021,” said Dr Andrew Chalmers, Founder of CiteAb. “This is a very exciting achievement, with data for the company demonstrating a quick upward trajectory in use of its protein products. In addition, congratulations to Sino Biological for also being named CiteAb Supplier Succeeding in SARS-CoV-2 Research. This is a phenomenal achievement, with data for the company demonstrating the huge impact its products have had in supporting researchers fighting the pandemic. I wish the whole team at Sino Biological many congratulations on these two worthy wins, and I wish the whole team at Sino Biological the very best for the year to come.”
Further commenting on the awards, CiteAb Data Product Manager, Rhys Bowen-Morris, stated, “The award of Supplier Succeeding in SARS-CoV-2 Research to Sino Biological was made based on our data gathered from the start of the COVID-19 pandemic onwards, analysis of which demonstrates that Sino Biological is the company that has seen the most citations for antibodies, kits and proteins with SARS-CoV-2 as a target during this time”. Rhys gave away free data for the top ten most-cited SARS-CoV-2 research antibodies, Sino Biological along with one other company dominating the top ten, and Sino Biological’s products accounting for 6 of the top ten products.
“We’re very excited to be highly commended as Protein Supplier to Watch in 2021, and be honored to win CiteAb award of Supplier Succeeding in SARS-CoV-2 Research,” Sino Biological CEO Dr. Jie Zhang stated, “We’re dedicated to virology and infectious disease research. These CiteAb awards have recognized our hard work and quick response to combat COVID-19. We will continue to spare no effort to develop high-quality reagents to accelerate biopharmaceutical and scientific research on the basis of our strong innovation capability.”
As the global leader in recombinant technology, Sino Biological’s team has developed 6,000+ high-quality recombinant proteins covering a variety of research areas such as drug targets, oncology, immune checkpoints, cytokines and infectious diseases. Over 85% of these proteins are expressed in eukaryotic cells, thus mimicking native protein structure, composition and function.
About Sino Biological
Sino Biological is an internationally recognized reagent supplier and contract research organization, specializing in recombinant protein production and antibody development. All of Sino Biological’s products are independently developed and produced, including 6,000+ recombinant proteins and 13,000+ antibodies. The company’s core technology platform is its in-house developed mammalian cell-based recombinant expression system enabling high-efficient production of antigens and antibodies. Sino Biological is dedicated to virology and infectious disease research. The company’s SARS-CoV-2 antibodies and antigens have been widely used to manufacture rapid antigen and antibody tests, and many of them have received the EUA from the FDA. Sino Biological has developed the world’s largest recombinant viral antigen bank, ProVir™. This viral antigen collection has been used worldwide in infectious disease research, therapeutic antibody evaluation, immunodiagnostic assay, and vaccine development. Learn more about Sino Biological here: https://www.sinobiological.com
About CiteAb
CiteAb is a leading life science data provider that helps researchers and their suppliers make more informed decisions. CiteAb’s search engine provides a simple way for researchers to find antibodies and other reagents that work, while their high quality life science market data, reagent product citations and published images are used commercially by many of the world’s leading reagent suppliers and investment companies. Learn more about CiteAb here: https://www.citeab.com
Contacts:
Sino Biological
Email: [email protected]
Phone: +1-215-583-7898
CiteAb
Email: [email protected]
This content was supplied by Sino Biological.